An Update on Glomerular Disease in the Elderly

Clinics in Geriatric Medicine

Volumn 29, Issue 3, 2013, Pages 579-591

  Glassock, Richard J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glomerulonephritis; Immunosuppressive therapy; Nephrotic syndrome; Primary glomerular disease; Secondary glomerular disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BORTEZOMIB; CHLORAMBUCIL; CORTICOTROPIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LENALIDOMIDE; LOOP DIURETIC AGENT; MELPHALAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMEGA 3 FATTY ACID; PREDNISONE; RENIN INHIBITOR; RITUXIMAB; STEROID; TACROLIMUS;

AGED; CLINICAL FEATURE; CRESCENTIC GLOMERULONEPHRITIS; DIABETES MELLITUS; DRUG EFFICACY; DRUG MEGADOSE; FATIGUE; FOCAL GLOMERULOSCLEROSIS; GASTROINTESTINAL SYMPTOM; GLOMERULOPATHY; GOODPASTURE SYNDROME; HEMATURIA; HUMAN; HYPERCHOLESTEROLEMIA; IDIOPATHIC NODULAR GLOMERULOSCLEROSIS; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; LOW DRUG DOSE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE DISEASE; MYALGIA; NEPHRITIS; NEPHROTIC SYNDROME; OSTEOPOROSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMAPHERESIS; PROGNOSIS; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; REVIEW; SKIN BRUISING; SLEEP DISORDER;

GLOMERULONEPHRITIS; IMMUNOSUPPRESSIVE THERAPY; NEPHROTIC SYNDROME; PRIMARY GLOMERULAR DISEASE; SECONDARY GLOMERULAR DISEASE;

AGED; AGED, 80 AND OVER; AGING; COMORBIDITY; DISEASE MANAGEMENT; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HUMANS; KIDNEY GLOMERULUS; NEPHROTIC SYNDROME; PATIENT ACUITY; PROGNOSIS; RISK FACTORS; URINALYSIS;

EID: 84880099353     PISSN: 07490690     EISSN: 18798853     Source Type: Journal    
DOI: 10.1016/j.cger.2013.05.007     Document Type: Review

References (40)

1. Faubert P.F., Porush J.G. Primary glomerular disease. Renal disease in the elderly 1998, 129-173. Marcel Dekker, Inc, New York. 2nd edition. P.F. Faubert, J.G. Porush (Eds.).
2. Glassock R.J. Glomerular disease in the elderly population. Nephrology and geriatrics integrated 2000, 57-66. Kluwer Academic Publishers, Dordrecht (The Netherlands). D.G. Oreopoulos, W.R. Hazzard, R. Luke (Eds.).
3. Becker G.J., Fairley K.F. Urinalysis. Textbook of nephrology 2001, 1765-1783. Lippincott Williams and Wilkins, Philadelphia. 4th edition. S. Massry, R. Glassock (Eds.).
4. Yokoyama H., Sugiyama H., Sato H., Committee for the Standardization of Renal Pathological Diagnosis and for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology, and the Progressive Renal Disease Research of the Ministry of Health, Labour and Welfare of Japan, et al. Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol 2012, 16(6):903-920.
5. Ponticelli C., Glassock R.J. Treatment of primary glomerulonephritis 2009, Oxford University Press, Oxford (United Kingdom), p. 1-476. 2nd edition.
6. Moutzouris D.A., Herlitz L., Appel G.A., et al. Renal biopsy in the very elderly. Clin J Am Soc Nephrol 2009, 4:1073-1082.
7. Vendemia F. The diagnosis of renal disease in elderly patients. What role is there for renal biopsy?. The aging kidney in health and disease 2008, 307-328. Springer, New York. J.F. Nunez, J.S. Cameron, D.G. Oreopoulos (Eds.).
8. Beck L.H., Salant D.J. Membranous nephropathy: recent travels and new roads ahead. Kidney Int 2010, 77(9):765-770.
9. Polanco N., Gutiérrez E., Covarsí A., Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrología, et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. JAm Soc Nephrol 2010, 21(4):697-704.
10. Pei Y., Cattran D., Greenwood C. Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 1992, 42:960-966.
11. Lionaki S., Derebail V.K., Hogan S.L., et al. Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol 2012, 7(1):43-51.
12. Qin W., Beck L.H., Zeng C., et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. JAm Soc Nephrol 2011, 22(6):1137-1143.
13. Glassock R.J. Prophylactic anti-coagulation in nephrotic syndrome: a clinical conundrum. JAm Soc Nephrol 2007, 18:2221-2225.
14. Passerini P., Ponticelli C. Membranous nephropathy. Treatment of primary glomerular disease 2009, 261-312. Oxford University Press, Oxford (United Kingdom). 2nd edition. C. Ponticelli, R. Glassock (Eds.).
15. Bomback A.S., Canetta P.A., Beck L.H., et al. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial. Am J Nephrol 2012, 36(1):58-67.
16. Ruggenenti P., Cravedi P., Chianca A., et al. Rituximab in idiopathic membranous nephropathy. JAm Soc Nephrol 2012, 23(8):1416-1425.
17. Chan T.M., Lin A.W., Tang S.C., et al. Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome. Nephrology (Carlton) 2007, 12(6):576-581.
18. Dussol B., Morange S., Burtey S., et al. Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial. Am J Kidney Dis 2008, 52(4):699-705.
19. Segarra A., Praga M., Ramos N., et al. Successful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitor-dependent patients. Clin J Am Soc Nephrol 2009, 4:1083-1088.
20. Moroni G., Ponticelli C. Acute post-infectious glomerulonephritis. Treatment of primary glomerular disease 2009, 153-178. Oxford University Press, Oxford (United Kingdom). 2nd edition. C. Ponticelli, R. Glassock (Eds.).
21. Glassock R.J., Lee G. Immunoglobulin A nephropathy. Treatment of primary glomerular disease 2009, 313-374. Oxford University Press, Oxford (United Kingdom). 2nd edition. C. Ponticelli, R. Glassock (Eds.).
22. Shin J.I., Lim B.J., Kim P.K., et al. Effects of cyclosporin A therapy combined with steroids and angiotensin converting enzyme inhibitors on childhood IgA nephropathy. JKorean Med Sci 2010, 25(5):723-727.
23. Ponticelli C., Glassock R.J. Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol 2010, 5(12):2363-2372.
24. Scolari F., Ponticelli C. Focal and segmental glomerulosclerosis. Treatment of primary glomerular disease 2009, 215-260. Oxford University Press, Oxford (United Kingdom). 2nd edition. C. Ponticelli, R. Glassock (Eds.).
25. Gipson D.S., Trachtman H., Kaskel F.J., et al. Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int 2011, 80(8):868-878.
26. Klemmer P.J., Chalermskulrat W., Reif M.S., et al. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 2003, 42(6):1149-1153.
27. Nachman P., Glassock R. Crescentic glomerulonephritis. Treatment of primary glomerular disease 2009, 399-434. Oxford University press, Oxford (United Kingdom). 2nd edition. C. Ponticelli, R. Glassock (Eds.).
28. Stone J.H., Merkel P.A., Spiera R., RAVE-ITN Research Group, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. NEngl J Med 2010, 363(3):221-232.
29. Coppo R., Ponticelli C. Minimal change nephropathy. Treatment of primary glomerular disease 2009, 179-214. Oxford University Press, Oxford (United Kingdom). 2nd edition. C. Ponticelli, R. Glassock (Eds.).
30. Brandão Tavares M., da Chagas de Almeida M., Martins R.T., et al. Acute tubular necrosis and renal failure in patients with glomerular disease. Ren Fail 2012, 34(10):1252-1257.
31. Beck L.H. Membranous nephropathy and malignancy. Semin Nephrol 2010, 30(6):635-644.
32. Bjoneklett R., Vikse B.E., Svarstad E., et al. Long-term risk of cancer in membranous nephropathy patients. Am J Kidney Dis 2007, 50:396-403.
33. Terrier B., Cacoub P. Cryoglobulinemia vasculitis: an update. Curr Opin Rheumatol 2013, 25(1):10-18.
34. Dember L.M. Amyloidosis-associated kidney disease. JAm Soc Nephrol 2006, 17:3458-3471.
35. Lin J., Markowitz G.A., Valeri A.M., et al. Renal immunoglobulin deposition disease: the clinical spectrum. JAm Soc Nephrol 2001, 12:1482-1492.
36. Sethi S., Theis J.D., Vrana J.A., et al. Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy. Clin J Am Soc Nephrol 2013, [Epub ahead of print].
37. Nasr S.H., D'Agati V.D. Nodular glomerulosclerosis in the nondiabetic smoker. JAm Soc Nephrol 2007, 18:2032-2036.
38. Cui Z., Zhao M.H. Advances in human antiglomerular basement membrane disease. Nat Rev Nephrol 2011, 7(12):697-705.
39. Levy J.B., Hammad T., Coulthart A., et al. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 2004, 66(4):1535-1540.
40. Levy J.B., Turner A.N., Rees A.J., et al. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001, 134(11):1033-1042.